ORBIMED ADVISORS LLC
Filing Date
Global Rank
#636
/ 8,605
▲ 108
· as of Mar 2026
Top Industry
Biotechnology
53.5%
3Y Alpha vs SPY
+2.3%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+88.4%
SPY
+76.5%
Annualised alpha
+2.7%
Max drawdown
−37.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
107 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
10.4%
+2.0 pts
Top 5
36.3%
+8.6 pts
Top 10
50.2%
+8.0 pts
HHI
374
Diversified+90
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $5,383,699,416 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
24 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | +4,604,802 | 10,570,300 | $28,962,622 | |
| RLMD | Relmada Therapeutics, Inc. | +2,105,264 | 4,715,864 | $32,822,413 | |
| LXEO | Lexeo Therapeutics, Inc. | +1,477,450 | 3,602,450 | $20,678,063 | |
| QURE | uniQure N.V. | +1,398,749 | 2,136,149 | $34,926,036 | |
| MLYS | Mineralys Therapeutics, Inc. | +1,072,500 | 2,052,900 | $55,613,061 | |
| DYN | Dyne Therapeutics, Inc. | +715,700 | 2,917,884 | $52,901,236 | |
| XENE | Xenon Pharmaceuticals Inc. | +612,771 | 1,059,971 | $61,637,313 | |
| PALI | Palisade Bio, Inc. | +461,580 | 2,333,000 | $4,082,750 | |
| BCAX | Bicara Therapeutics Inc. | +458,200 | 667,300 | $13,272,597 | |
| GPCR | Structure Therapeutics Inc. | +313,600 | 1,475,403 | $71,114,424 | |
| PFE | Pfizer Inc | +293,600 | 1,946,500 | $54,657,720 | |
| BMY | Bristol Myers Squibb Co | +150,000 | 925,000 | $56,101,250 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | +140,000 | 1,737,287 | $16,313,124 | |
| ABVX | Abivax S.A. | +97,800 | 465,700 | $51,855,695 | |
| PRAX | Praxis Precision Medicines, Inc. | +78,000 | 172,500 | $55,577,775 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +74,300 | 314,100 | $27,317,277 | |
| ANRO | Alto Neuroscience, Inc. | +42,500 | 167,500 | $3,765,400 | |
| RVMD | Revolution Medicines, Inc. | +26,100 | 52,000 | $5,057,000 | |
| PTCT | Ptc Therapeutics, Inc. | +25,900 | 49,100 | $3,345,183 | |
| PTGX | Protagonist Therapeutics, Inc | +20,400 | 42,100 | $4,437,340 | |
| VERA | Vera Therapeutics, Inc. | +16,096 | 369,596 | $14,868,847 | |
| ELV | Elevance Health, Inc. | +15,600 | 114,700 | $33,578,425 | |
| ASND | Ascendis Pharma A/S | +10,000 | 181,977 | $41,623,599 | |
| BTSG | BrightSpring Health Services, Inc. | +9,300 | 497,800 | $21,211,258 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ADCT | ADC Therapeutics SA | −4,504,828 | 1,318,026 | $4,942,597 | |
| EYPT | EyePoint, Inc. | −1,399,167 | 1,069,147 | $13,781,304 | |
| JANX | Janux Therapeutics, Inc. | −970,826 | 983,600 | $13,672,040 | |
| ORIC | Oric Pharmaceuticals, Inc. | −947,827 | 2,693,929 | $34,132,080 | |
| EW | Edwards Lifesciences Corp | −762,300 | 1,230,600 | $98,546,448 | |
| TRVI | Trevi Therapeutics, Inc. | −736,300 | 2,454,400 | $29,280,992 | |
| AVTX | Avalo Therapeutics, Inc. | −712,135 | 475,165 | $7,094,213 | |
| CGON | CG Oncology, Inc. | −568,283 | 948,267 | $64,178,710 | |
| ALMS | Alumis Inc. | −554,567 | 548,163 | $12,076,030 | |
| CCCC | C4 Therapeutics, Inc. | −548,549 | 856,353 | $2,252,208 | |
| TECX | Tectonic Therapeutic, Inc. | −348,000 | 226,600 | $7,004,206 | |
| JBIO | Jade Biosciences, Inc. | −346,152 | 185,011 | $2,599,404 | |
| BCRX | Biocryst Pharmaceuticals Inc | −316,600 | 1,425,200 | $13,567,904 | |
| NPCE | NeuroPace Inc | −309,808 | 2,096,527 | $27,569,330 | |
| CAI | Caris Life Sciences, Inc. | −309,200 | 2,806,811 | $50,185,780 | |
| MBX | MBX Biosciences, Inc. | −297,316 | 3,637,887 | $108,590,926 | |
| KALV | KalVista Pharmaceuticals, Inc. | −288,000 | 94,400 | $1,900,272 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | −169,800 | 119,000 | $39,373,530 | |
| SYK | Stryker Corp | −142,500 | 182,500 | $59,967,675 | |
| NTRA | Natera, Inc. | −103,800 | 262,000 | $52,397,380 | |
| BIOA | BioAge Labs, Inc. | −79,090 | 711,811 | $12,449,574 | |
| LLY | ELI LILLY & Co | −64,400 | 236,800 | $217,801,536 | |
| ISRG | Intuitive Surgical Inc | −54,700 | 208,700 | $96,208,613 | |
| KRYS | Krystal Biotech, Inc. | −50,700 | 69,100 | $17,849,912 | |
| COGT | Cogent Biosciences, Inc. | −48,900 | 322,100 | $12,397,629 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MYGN | Myriad Genetics Inc | 125,000,000 | $562,500,000 | |
| RCEL | AVITA Medical, Inc. | 82,010,995 | $303,440,681 | |
| MDXH | MDxHealth SA | 124,306,000 | $285,903,800 | |
| AZN | Astrazeneca PLC | 670,200 | $132,176,844 | |
| MRK | Merck & Co., Inc. | 663,400 | $79,800,386 | |
| GH | Guardant Health, Inc. | 435,200 | $40,199,424 | |
| PVLA | Palvella Therapeutics, Inc. | 184,600 | $23,010,390 | |
| SNDX | Syndax Pharmaceuticals Inc | 962,300 | $22,479,328 | |
| STRO | Sutro Biopharma, Inc. | 801,144 | $19,956,497 | |
| NKTR | Nektar Therapeutics | 275,000 | $19,786,250 | |
| DFTX | Definium Therapeutics, Inc. | 804,000 | $15,195,600 | |
| AMGN | Amgen Inc | 39,900 | $14,038,815 | |
| ALHC | Alignment Healthcare, Inc. | 791,000 | $13,937,420 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 14,700 | $11,357,808 | |
| BIIB | Biogen Inc. | 61,600 | $11,293,128 | |
| QGEN | Qiagen N.V. | 250,000 | $10,010,000 | |
| GILD | Gilead Sciences, Inc. | 59,600 | $8,306,452 | |
| HRTX | Heron Therapeutics, Inc. /De/ | 9,816,940 | $7,853,552 | |
| CMPS | COMPASS Pathways plc | 1,150,646 | $6,363,072 | |
| ALXO | Alx Oncology Holdings Inc | 2,866,256 | $5,746,843 | |
| AORT | Artivion, Inc. | 151,000 | $5,529,620 | |
| SVRA | Savara Inc | 635,000 | $3,467,100 | |
| SLNO | Soleno Therapeutics Inc | 100,000 | $3,348,000 | |
| LFST | LifeStance Health Group, Inc. | 500,000 | $3,185,000 | |
| DRUG | Bright Minds Biosciences Inc. | 40,000 | $2,918,800 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
17 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | 2,153,300 | $86,993,320 | |
| APLS | Apellis Pharmaceuticals, Inc. | 2,429,868 | $61,038,284 | |
| CI | Cigna Group | 205,000 | $56,422,150 | |
| UTHR | UNITED THERAPEUTICS Corp | 105,200 | $51,258,700 | |
| ROIV | Roivant Sciences Ltd. | 2,190,907 | $47,542,681 | |
| NBIX | Neurocrine Biosciences Inc | 314,240 | $44,568,659 | |
| EXAS | EXACT SCIENCES CORP | 351,716 | $35,720,276 | |
| BRKR | Bruker Corp | 555,789 | $26,183,219 | |
| CTMX | CytomX Therapeutics, Inc. | 3,525,650 | $15,019,269 | |
| VIR | Vir Biotechnology, Inc. | 2,380,715 | $14,355,711 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 154,400 | $12,642,272 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 729,900 | $10,393,776 | |
| CELC | Celcuity Inc. | 85,664 | $8,544,127 | |
| PMVP | PMV Pharmaceuticals, Inc. | 4,975,291 | $6,219,113 | |
| INSM | INSMED Inc | 25,400 | $4,420,616 | |
| OCUL | Ocular Therapeutix, Inc | 157,300 | $1,909,622 | |
| MPLT | MapLight Therapeutics, Inc. | 56,000 | $983,640 | |
| No positions match the current search. | ||||
107 positions ·
$5,383,699,416 total
· as of Mar 31, 2026
Showing 1–50
of 107 positions by value
· page 1 of 3
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MYGN |
Myriad Genetics Inc
Healthcare
|
NEW | 125,000,000 | $562,500,000 | 10.45% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 15,518,492 | $488,832,498 | 9.08% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Held | 7,959,538 | $312,013,889 | 5.80% | |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
NEW | 82,010,995 | $303,440,681 | 5.64% | |
| MDXH |
MDxHealth SA
Healthcare
|
NEW | 124,306,000 | $285,903,800 | 5.31% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 236,800 | $217,801,536 | 4.05% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 2,382,100 | $149,476,775 | 2.78% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Reduced | 3,530,702 | $141,545,843 | 2.63% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 670,200 | $132,176,844 | 2.46% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Reduced | 3,637,887 | $108,590,926 | 2.02% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Held | 7,165,006 | $104,824,037 | 1.95% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 136,900 | $99,971,225 | 1.86% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 1,230,600 | $98,546,448 | 1.83% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 208,700 | $96,208,613 | 1.79% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Held | 15,219,994 | $80,513,768 | 1.50% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
NEW | 663,400 | $79,800,386 | 1.48% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 1,475,403 | $71,114,424 | 1.32% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Held | 3,027,328 | $69,840,456 | 1.30% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 1,067,550 | $68,259,147 | 1.27% | |
| SPRY |
ARS Pharmaceuticals, Inc.
Healthcare
|
Held | 8,288,510 | $66,556,735 | 1.24% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 948,267 | $64,178,710 | 1.19% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 1,059,971 | $61,637,313 | 1.14% | |
| SYK |
Stryker Corp
Healthcare
|
Reduced | 182,500 | $59,967,675 | 1.11% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Added | 925,000 | $56,101,250 | 1.04% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 2,052,900 | $55,613,061 | 1.03% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 172,500 | $55,577,775 | 1.03% | |
| PFE |
Pfizer Inc
Healthcare
|
Added | 1,946,500 | $54,657,720 | 1.02% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 2,917,884 | $52,901,236 | 0.98% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 262,000 | $52,397,380 | 0.97% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 465,700 | $51,855,695 | 0.96% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Held | 5,693,589 | $51,242,301 | 0.95% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Reduced | 265,800 | $50,395,680 | 0.94% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
Reduced | 2,806,811 | $50,185,780 | 0.93% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 181,977 | $41,623,599 | 0.77% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
Held | 6,306,127 | $40,548,396 | 0.75% | |
| GH |
Guardant Health, Inc.
Healthcare
|
NEW | 435,200 | $40,199,424 | 0.75% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 119,000 | $39,373,530 | 0.73% | |
| PRLD |
Prelude Therapeutics Inc
Healthcare
|
Held | 10,909,256 | $37,309,655 | 0.69% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Held | 999,000 | $36,283,680 | 0.67% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 213,921 | $36,156,927 | 0.67% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 2,136,149 | $34,926,036 | 0.65% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,693,929 | $34,132,080 | 0.63% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 114,700 | $33,578,425 | 0.62% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
Added | 4,715,864 | $32,822,413 | 0.61% | |
| FBRX |
Forte Biosciences, Inc.
Healthcare
|
Held | 1,196,955 | $31,001,134 | 0.58% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Reduced | 2,454,400 | $29,280,992 | 0.54% | |
| ESPR |
Esperion Therapeutics, Inc.
Healthcare
|
Added | 10,570,300 | $28,962,622 | 0.54% | |
| NPCE |
NeuroPace Inc
Healthcare
|
Reduced | 2,096,527 | $27,569,330 | 0.51% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 314,100 | $27,317,277 | 0.51% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
NEW | 184,600 | $23,010,390 | 0.43% |